Inhibition of factor B, the alternative complement pathway and methods related thereto

Details for Australian Patent Application No. 2005212369 (hide)

Owner Medical University of South Carolina Foundation for Research Development National Jewish Medical and Research Center The Regents of the University of Colorado

Inventors Gelfand, Erwin W.; Holers, Vernon Michael; Gilkeson, Gary Steven; Thurman, Joshua M.; Taube, Christian

Agent Madderns

Pub. Number AU-B-2005212369

PCT Pub. Number WO2005/077417

Priority 60/636,239 14.12.04 US; 60/543,594 10.02.04 US; PCT/ US2004/015040 13.05.04 US

Filing date 10 February 2005

Wipo publication date 25 August 2005

Acceptance publication date 23 June 2011

International Classifications

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/077417 Priority application(s): WO2005/077417

23 June 2011 Application Accepted

  Published as AU-B-2005212369

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212370-Glycine and/or for use in cartilage affecting conditions

2005212365-Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir